PINK

Simplify Health Care ETF

HealthcarePSESimplify ETF
$39.72
$-0.13 (-0.32%)
Delayed ≥20 min · Sep 3, 2026

Key Statistics

Net Assets (AUM)
$234.20M
Expense Ratio
See prospectus
Previous Close
$39.85
Day Range
- – -
52-Week Range
$30.16 – $40.63
Volume
37.11K
Avg Vol (50D)
80.20K
Beta
0.73

Historical Performance

1M
+0.10%
3M
+5.30%
6M
+15.69%
YTD
+8.84%
1Y
+31.34%
3Y
+55.44%
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

UTHR United Therapeutics Corporation 8.77%
ALGN Align Technology Inc. 7.91%
LLY Eli Lilly & Co. 6.63%
4519 Chugai Pharmaceutical Co Ltd. 5.21%
NVO Novo Nordisk A/S 5.19%
ABBV AbbVie Inc. 4.56%
JAZZ Jazz Pharmaceuticals PLC 4.22%
PCT PURECYCLE TECHNOLOGIES INC 3.97%
TMO Thermo Fisher Scientific Inc 3.69%
GILD Gilead Sciences Inc. 3.69%
REGN Regeneron Pharmaceuticals, Inc. 3.63%
BHVN Biohaven Ltd 3.28%
TXG 10X Genomics Inc 3.23%
JNJ Johnson & Johnson 2.83%
MMM 3M Company 2.72%
WRBY Warby Parker Inc 2.64%
DHR Danaher Corporation 2.64%
BNTC Benitec Biopharma Inc 2.58%
AMGN Amgen Inc. 2.41%
AZN AstraZeneca PLC 2.20%
ISRG Intuitive Surgical Inc. 2.14%
CVS CVS Health Corp 1.63%
VRTX Vertex Pharmaceuticals Incorporated 1.53%
EYPT Eyepoint Inc. 1.52%
ALHC Alignment Healthcare Inc 1.45%

Top 25 holdings as of Mar 31, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About PINK

Principal Investment Strategies: The Fund has adopted a non-fundamental policy that, under normal circumstances, the Fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The Fund defines health care companies as companies included in the Global Industry Classification Standard health care sector. The Fund defines equity securities as common stock, preferred stock, or ETFs that invest in the same. The Fund invests in companies without restriction as to capitalization, including micro-capitalization companies. TheFund will invest in 50 to 100 health care companies. The Fund will use fundamental, bottom-up analysis that seeks to identify high-qualitycompanies and the most compelling investment opportunities. In general, the Fund will follow a growth investment strategy, seeking companieswhose earnings are expected to grow faster than inflation and the economy in general. When stock valuations seem unusually high, however,a “value” approach, which gives preference to seemingly undervalued companies, may be emphasized. The Fund generally seeksinvestments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs orimprove quality in health care systems. The Fund may invest in health care companies that do not seek to design or develop treatmentsfor breast cancer. The Adviser may invest in affiliated money market ETFs to manage liquidity. The Fund’s namesake is The Susan G. Komen Breast Cancer Foundation, Inc. (the “Foundation”), a 501(c)(3) charitable foundation. In exchange for the use of its name and logo, Simplify Asset Management Inc., the Fund’s investment adviser (the “Adviser”), will donate its annual management fee for managing the Fund to the Foundation. The Foundation shall use such donation to support its mission, but the Foundation will not participate in or have any influence on the day-to-day operations of the Fund or the Adviser’s management of the Fund. The Fund is not organized as a charitable investment trust.

Data for PINK is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.